OOIR: Observatory of International Research

Papers

(The H4-Index of Annals of Allergy Asthma & Immunology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Atopic dermatitis in the pediatric population	162
New treatments in atopic dermatitis	112
Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis	76
The infectious complications of atopic dermatitis	72
The journey to a respiratory syncytial virus vaccine	69
Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States	61
Asthma and the social determinants of health	60
Potential association of mast cells with coronavirus disease 2019	59
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma	58
Smell loss is a prognostic factor for lower severity of coronavirus disease 2019	53
Biologics in chronic rhinosinusitis with nasal polyposis	52
Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis	49
The COVID-19 pandemic	47
New and emerging treatments for inflammatory itch	47
Prevalence and natural history of tree nut allergy	46
Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019	45
Children with reported penicillin allergy	42
Hereditary alpha-tryptasemia in 101 patients with mast cell activation–related symptomatology including anaphylaxis	42
Key steps in vaccine development	42
The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection	40
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis	40
Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters	40
The impact of psychological stress on mast cells	39
Patient satisfaction with telemedicine encounters in an allergy and immunology practice during the coronavirus disease 2019 pandemic	38
Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions	38

Secondary immunodeficiencies	37
Phenotypes and endotypes in eosinophilic esophagitis	37
AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis	36
The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019	36
Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines	33
Development and acceptability of a shared decision-making tool for commercial peanut allergy therapies	32
Chronic stress and asthma in adolescents	32